The company

GlobalData Healthcare is a healthcare data platform and the largest division of AIM-listed GlobalData, headquartered in the UK and employing over 1,000 people across 10 countries. Its subscription service offers a one-stop data solution for over 2,000 global customers across large global pharma, pharma & biotech, pharma suppliers, professional services and medical devices manufacturers.

Inflexion partnered with GlobalData to carve out its Healthcare division as a standalone entity, allowing GlobalData to retain a majority stake in the business.

The Inflexion difference

GlobalData and Inflexion are working together to accelerate organic growth primarily through securing new clients globally and further cross-selling to existing clients, continuing to invest in the product and content, as well as pursuing selective M&A.

This is a significant milestone in GlobalData’s evolution and we are delighted to welcome Inflexion as a shareholder in our Healthcare division. This investment highlights the significant value in our unique data platform and gives us the flexibility to launch a more ambitious approach to growth investment across our portfolio. We believe that we can create substantial value for all shareholders and accelerate GlobalData’s profitable growth over the coming years.

Mike Danson, CEO, GlobalData